You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《即日市評》恆指失萬七關 友邦績後跌4% 藥明系捱沽
恆指今日持續向下,失守萬七關。市場觀望美國今晚公布生產者物價指數,美美股道指及納指隔晚各升0.1%及跌0.5%,執筆之時,美國10年期債券孳息率升至4.206厘,美匯指數處於102.89,道指期貨最新升121點或0.31%,納指期貨最新升0.5%。上證綜指全日跌5點或0.18%收3,038點,深證成指跌0.52%,而滬深兩市成交額共1萬億人民幣。 恆指高開38點,早段一度升127點高見17,209點,其後回落,午後曾跌204點低見16,878點,全日跌120點或0.7%,收16,961點;國指跌25點或0.4%,收5,906點;恆生科技指數跌52點或1.4%,收3,603點。大市全日成交總額1,131.31億元,滬、深港通南下交易淨流入29.92億及16.59億元人民幣。 科技股方面,阿里(09988.HK)跌0.7%、騰訊(00700.HK)走低近0.5%、百度(09888.HK)及網易(09999.HK)各跌0.5%至0.7%。美國生物技術創新組織(BIO)轉撐《生物安全法案》,並採取措施剔除藥明康德(02359.HK)的會員資格。藥明系重挫,藥明康德及藥明生物(02269.HK)跌12.1%及13.1%,藥明合聯(02268.HK)下挫18%。 【科技股偏淡 友邦績後弱】 友邦(01299.HK)去年新業務價值40.34億美元,按實質匯率計升30%符預期,摩根大通指業績其中之一關注點是公司未有披露新的股份回購計劃,友邦全日跌4%收62.25。友邦於2022年3月宣布未來三年進行100億美元股份回購計劃,截至去年底,已回購股份總值72.07億美元。 友邦保險首席執行官兼總裁李源祥表示,今年首兩個月內地和香港新業務價值錄雙位數增長,顯示增長勢頭良好。友邦區域首席執行官及集團首席分銷總監陳榮聲稱,有信心訪港內地客需求持續。內地時隔十六年擴大自由行城市,將個人遊計劃的適用城市進一步擴展至西安及青島,屬多年來再次擴大,由於兩個城市規模大,而且目前訪港內地旅客數字仍未全面恢復,因此相信訪港客戶投保人數仍有很大的增長空間。 【跌股一千隻 內房股造淡】 港股今日市寬轉弱,主板股票的升跌比率為17比26(上日為19比24),下跌股份1,079隻(跌幅2.7%),恆指成份股今日31隻股份上升,48隻股份下跌,升跌比率為38比59(上日為39比52);大市今日錄沽空224.26億元,佔可沽空股份成交額1,017.61億元的22.038%(上日為21.08%)。 內房股方面,綠城中國(03900.HK)及旭輝(00884.HK)今日股價各升2.7%及3.1%,龍湖(00960.HK)升2.1%。杭州市房地產市場平穩健康發展領導小組辦公室發布進一步優化房地產市場調控措施通知,要求加大規劃建設保障性住房力度,加快房源籌建,今年開工建設配售型保障性住房不少於6,000套,著力解決工薪收入群體住房困難。 該通知明確優化二手住房限購政策,在該市範圍內購買二手住房,不再審核購房人資格,並明確優化增值稅徵免年限,在該市範圍內個人出售住房的增值稅徵免年限統一調整為兩年。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account